Australia markets closed

Bellevue Life Sciences Acquisition Corp. (BLACW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.02010.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-21.458
403.78
-35.388
-3.308
Change in working capital
18.054
1,553
31.153
2.847
Accounts payable
1,162
1,035
31.153
-
Other working capital
-3.404
-818.766
-4.235
-0.461
Other non-cash items
-2,838
-2,775
-
-
Net cash provided by operating activities
-3.404
-818.766
-4.235
-0.461
Cash flows from investing activities
Other investing activities
36,258
-33,830
-
-
Net cash used for investing activities
36,258
-33,830
0
-
Cash flows from financing activities
Debt repayment
0
-1,200
0
-
Common stock issued
0
63,970
0
0
Common stock repurchased
-
-35,996
0
-
Other financing activities
-436.764
-1,392
-676.021
-157.435
Net cash used provided by (used for) financing activities
63.236
34,539
123.979
-57.435
Net change in cash
59.832
-109.082
119.744
-57.896
Cash at beginning of period
9.003
124.501
4.757
62.653
Cash at end of period
68.835
15.419
124.501
4.757
Free cash flow
Operating cash flow
-3.404
-818.766
-4.235
-0.461
Free cash flow
-3.404
-818.766
-4.235
-0.461